OBJECTIVE: To investigate the role of junctional adhesion molecule-A (JAM-A) in the pathogenesis of systemic sclerosis (SSc). METHODS: Biopsy specimens from proximal and distal arm skin and serum were obtained from patients with SSc and normal volunteers. To determine the expression of JAM-A on SSc dermal fibroblasts and in SSc skin, cell surface ELISAs and immunohistology were performed. An ELISA was designed to determine the amount of soluble JAM-A (sJAM-A) in serum. Myeloid U937 cell-SSc dermal fibroblast and skin adhesion assays were performed to determine the role of JAM-A in myeloid cell adhesion. RESULTS: The stratum granulosum and dermal endothelial cells (ECs) from distal arm SSc skin exhibited significantly decreased expression of JAM-A in comparison with normal volunteers. However, sJAM-A was increased in the serum of patients with SSc compared with normal volunteers. Conversely, JAM-A was increased on the surface of SSc compared with normal dermal fibroblasts. JAM-A accounted for a significant portion of U937 binding to SSc dermal fibroblasts. In addition, JAM-A contributed to U937 adhesion to both distal and proximal SSc skin. CONCLUSIONS: JAM-A expression is dysregulated in SSc skin. Decreased expression of JAM-A on SSc ECs may result in a reduced response to proangiogenic basic fibroblast growth factor. Increased JAM-A expression on SSc fibroblasts may serve to retain myeloid cells, which in turn secrete angiogenic factors.
OBJECTIVE: To investigate the role of junctional adhesion molecule-A (JAM-A) in the pathogenesis of systemic sclerosis (SSc). METHODS: Biopsy specimens from proximal and distal arm skin and serum were obtained from patients with SSc and normal volunteers. To determine the expression of JAM-A on SSc dermal fibroblasts and in SSc skin, cell surface ELISAs and immunohistology were performed. An ELISA was designed to determine the amount of soluble JAM-A (sJAM-A) in serum. Myeloid U937 cell-SSc dermal fibroblast and skin adhesion assays were performed to determine the role of JAM-A in myeloid cell adhesion. RESULTS: The stratum granulosum and dermal endothelial cells (ECs) from distal arm SSc skin exhibited significantly decreased expression of JAM-A in comparison with normal volunteers. However, sJAM-A was increased in the serum of patients with SSc compared with normal volunteers. Conversely, JAM-A was increased on the surface of SSc compared with normal dermal fibroblasts. JAM-A accounted for a significant portion of U937 binding to SSc dermal fibroblasts. In addition, JAM-A contributed to U937 adhesion to both distal and proximal SSc skin. CONCLUSIONS:JAM-A expression is dysregulated in SSc skin. Decreased expression of JAM-A on SSc ECs may result in a reduced response to proangiogenic basic fibroblast growth factor. Increased JAM-A expression on SSc fibroblasts may serve to retain myeloid cells, which in turn secrete angiogenic factors.
Authors: E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim Journal: J Rheumatol Date: 1988-02 Impact factor: 4.666
Authors: Bradley J Rabquer; Angela Pakozdi; James E Michel; Bansari S Gujar; G Kenneth Haines; Beat A Imhof; Alisa E Koch Journal: Arthritis Rheum Date: 2008-10
Authors: A Del Maschio; A De Luigi; I Martin-Padura; M Brockhaus; T Bartfai; P Fruscella; L Adorini; G Martino; R Furlan; M G De Simoni; E Dejana Journal: J Exp Med Date: 1999-11-01 Impact factor: 14.307
Authors: Elena Schiopu; Karen M Au; Maureen A McMahon; Mariana J Kaplan; Anagha Divekar; Ram R Singh; Daniel E Furst; Philip J Clements; Nagesh Ragvendra; Wenpu Zhao; Paul Maranian; Dinesh Khanna Journal: Rheumatology (Oxford) Date: 2013-12-19 Impact factor: 7.580
Authors: Francesco Paolo Cantatore; Nicola Maruotti; Addolorata Corrado; Domenico Ribatti Journal: Biomed Res Int Date: 2017-07-16 Impact factor: 3.411
Authors: Maynara Santana-Gonçalves; Djúlio Zanin-Silva; Álvaro Henrique-Neto; Daniela A Moraes; Marianna Y Kawashima-Vasconcelos; João R Lima-Júnior; Juliana B E Dias; Vinícius Bragagnollo; Júlia T C de Azevedo; Dimas T Covas; Kelen C R Malmegrim; Leandra Ramalho; Maria Carolina Oliveira Journal: Ther Adv Musculoskelet Dis Date: 2022-03-28 Impact factor: 5.346